Bioethics News

Jury Still Out on Stem Cells for Heart Failure

August 29, 2016

(Med Page Today) – Wide variety in methods for trials of stem cell therapies for heart failure are a big reason for the inconsistent results in the literature, according to a review article. Over the last 20 years, researchers have gotten closer to their goal of bringing stem cell regenerative medicine to patients with heart failure, wrote Joseph C. Wu, MD, PhD, of Stanford University School of Medicine, Calif., and colleagues online in JAMA Cardiology.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.